Allurion Technologies, Inc. (ALUR) Stock Price

ALURStock

$1.90−93.71%52W

Market Cap$1.90M

P/E—

PEG Ratio—

Div yield—

Beta-0.07

ALUR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-99.28%

Price vs S&P 500 (4W)-59.45%

VGM Score32.53

Book Value / Share (Quarterly)$-1.11

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-38.10%

Cash Flow / Share (Quarterly)$0.42

Price vs S&P 500 (YTD)-100.12%

Gross Margin (TTM)52.70%

Net Profit Margin (TTM)-264.74%

EPS (TTM)$-3.85

10-Day Avg Trading Volume0.01M

EPS Excl Extra (TTM)$-3.85

EPS (Annual)$-3.81

ROI (Annual)-39.99%

Gross Margin (Annual)62.84%

Net Profit Margin (5Y Avg)-90.63%

Cash / Share (Quarterly)$0.34

Revenue Growth QoQ (YoY)-47.19%

ROA (Last FY)-182.32%

Revenue Growth TTM (YoY)-55.49%

EBITD / Share (TTM)$-2.77

Operating Margin (TTM)-216.46%

Cash Flow / Share (Annual)$-2.36

Net Income / Employee (Annual)$-756,700

EV / Revenue (TTM)2.03x

Net Interest Coverage (TTM)-1.46x

ROA (TTM)-175.34%

EPS Incl Extra (Annual)$-3.81

Current Ratio (Annual)0.33x

Quick Ratio (Quarterly)0.23x

3-Month Avg Trading Volume0.00M

52-Week Price Return-93.71%

Revenue / Employee (TTM)$331,500

Tangible BV / Share (Quarterly)$-1.11

P/S Ratio (Annual)0.14x

Asset Turnover (Annual)0.97x

52-Week High$34.50

Operating Margin (5Y Avg)-131.53%

EPS Excl Extra (Annual)$-3.81

26-Week Price Return-88.04%

Quick Ratio (Annual)0.24x

13-Week Price Return-85.27%

Total Debt / Equity (Annual)5.40x

Current Ratio (Quarterly)0.30x

Enterprise Value$25.56M

Asset Turnover (TTM)0.66x

Revenue / Employee (Annual)$400,800

Inventory Turnover (Annual)1.86x

Pretax Margin (Annual)-188.32%

Cash / Share (Annual)$0.44

3-Month Return Std Dev181.69%

Gross Margin (5Y Avg)72.55%

Net Income / Employee (TTM)$-877,600

ROE (Last FY)-255.99%

Net Interest Coverage (Annual)-1.28x

EPS Basic Excl Extra (Annual)$-3.81

Receivables Turnover (TTM)2.14x

EV / Free Cash Flow (TTM)4.09x

EPS Incl Extra (TTM)$-3.85

Receivables Turnover (Annual)2.75x

P/S Ratio (TTM)0.16x

Pretax Margin (5Y Avg)-89.95%

Revenue / Share (Annual)$2.02

Tangible BV / Share (Annual)$-0.76

Price vs S&P 500 (52W)-112.02%

Year-to-Date Return-89.11%

5-Day Price Return-27.17%

EPS Normalized (Annual)$-3.81

ROA (5Y Avg)-84.32%

Net Profit Margin (Annual)-188.80%

Month-to-Date Return-53.26%

Cash Flow / Share (TTM)$-1.74

EBITD / Share (Annual)$-4.02

Operating Margin (Annual)-202.34%

LT Debt / Equity (Annual)0.41x

P/CF (TTM)0.33x

EPS Basic Excl Extra (TTM)$-3.85

Inventory Turnover (TTM)2.20x

Pretax Margin (TTM)-264.73%

Book Value / Share (Annual)$-0.76

Price vs S&P 500 (13W)-88.07%

Beta-0.07x

Revenue / Share (TTM)$0.94

52-Week Low$1.70

vGradeA

gGradeF

mGradeF

vgmGradeD

ALUR Earnings Surprise History

Q2 25-13.10est. -13.35

Q3 25-17.75est. -36.75

Q4 25-5.44est. -9.45

Q1 26-6.90est. -5.10

ALUR Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.25

4.29

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
ALURAllurion Technologies, Inc.	A	F	F	$1.90
SYKStryker Corporation	C	B	C	$330.59
MMM3M Company	C	D	B	$179.37
BSXBoston Scientific Corp.	C	B	D	$49.86
BDXBecton, Dickinson and Co.	B	D	B	$189.78
MDLNMedline Inc. Class A common stock	C	D	C	$35.64
RMDResMed Inc.	C	B	C	$236.59
DXCMDexCom, Inc.	D	B	B	$89.16
WSTWest Pharmaceutical Services, Inc.	D	C	B	$348.48
SOLVSolventum Corporation	C	C	B	$91.61
BAXBaxter International Inc.	B	D	B	$26.29
PENPenumbra, Inc.	D	C	C	$324.37
GMEDGLOBUS MEDICAL INC	B	B	C	$82.96
GKOSGlaukos Corporation	F	A	A	$181.39
PODDInsulet Corporation	C	A	D	$143.05
STVNStevanato Group S.p.A.	D	C	B	$22.70
TFXTeleflex Incorporated	B	F	B	$140.18
MMSIMerit Medical Systems Inc	C	B	B	$91.09
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$18.92
HAEHaemonetics Corporation	C	C	A	$108.32
ICUIICU Medical Inc	C	D	B	$182.24
HTFLHeartflow, Inc. Common Stock	—	A	A	$49.89
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$123.09
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$49.00
ATRCAtriCure, Inc.	D	B	A	$48.68
UFPTUFP Technologies Inc	C	B	B	$304.21
NVCRNovoCure Limited Ordinary Shares	D	C	C	$17.62
LMATLeMaitre Vascular, Inc.	C	B	D	$78.97
INSPInspire Medical Systems, Inc.	B	B	B	$61.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$26.92
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.58
ATECAlphatec Holdings, Inc.	D	B	C	$9.33
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.70
IARTIntegra LifeSciences Holdings	B	D	C	$16.79
AORTArtivion, Inc.	C	C	C	$26.38
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$21.60
IRMDiRadimed Corporation	D	B	C	$87.87
BVSBioventus Inc. Class A Common Stock	B	C	A	$14.08
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.60
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.54
BBNXBeta Bionics, Inc. Common Stock	D	A	A	$19.34
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.55
ANGOAngioDynamics, Inc.	C	D	B	$15.95
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$24.50
MDXGMiMedx Group, Inc	C	D	C	$4.34
DCTHDelcath Systems Inc	D	B	A	$16.92
BWAYBrainsway Ltd. American Depositary Shares	F	A	C	$14.43
CERSCerus Corp	D	C	B	$2.72
TCMDTactile Systems Technology, Inc.	B	B	C	$23.58
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$16.96
NPCENeuropace, Inc. Common Stock	D	C	C	$14.16

About Allurion Technologies, Inc.

Allurion Technologies develops a minimally invasive weight loss platform centered on the Allurion Balloon, a swallowable intragastric balloon that requires no surgery, endoscopy, or anesthesia. The platform combines the proprietary balloon with AI-powered remote patient monitoring, a behavior modification program, and virtual care services delivered through its proprietary Allurion VCS. This non-procedural approach addresses a significant market opportunity in weight management for overweight patients seeking alternatives to invasive interventions.